Published in Physician Law Weekly, December 8th, 2004
OrthoLogic reported a net loss of $29.4 million, or $.80 per share, for the third quarter ended Sept. 30, 2004. For the nine months ended Sept. 30, 2004, OrthoLogic reported a net loss of $36.8 million, or $1.04 per share.
The company said that third quarter and 9-month expenses for continuing operations compared with prior year increased as a result of the company's expanded efforts in research, development and clinical activities, as well as the Chrysalis Biotechnology, Inc....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly